info@projectetris.eu

Project Partners

Neolys Diagnostics

Neolys Diagnostics is a Biotechnology company specialized in precision medicine for radiation oncology, Neolys Diagnostics develops innovative medical tests combining DNA repair biomarkers and radiotherapy treatment parameters to anticipate and reduce treatment-related side effects, optimize therapeutic efficacy, and contribute to healthcare cost reduction through personalized radiotherapy strategies. 

Dr. Pereira, Sandrine is the Scientific Director of Neolys Diagnostics. With over 15 years of experience in radiosensitivity testing and oncology innovation, Sandrine Pereira leads Work Package 8 (WP8) within the TETRIS Project, ensuring scientific coherence between functional biomarkers, genetic data, and clinical application. Her Team members are Mathilde Hà-Lasnon and Laura Desrivot. 

Neolys Diagnostics – WP8 Leadership: Cellular Sensitivity Testing in the TETRIS Prospective Cohort. 
WP8 focuses on the assessment of cellular radiosensitivity and the integration of functional biomarkers with genetic information, including Polygenic Risk Scores (PRS) derived from SNP analysis, enabling multidimensional patient risk profiling. RadioDTect© and RadioProfile© Assays are Functional radiosensitivity testing assays. The RadioDTect© blood test and RadioProfile© skin test are performed on biological samples collected using standardized protocols from patients enrolled in the TETRIS prospective cohort (WP9). 

Neolys Diagnostics is also part of WP4-Integration of functional and genomic data and WP7- Biological input for Digital Twin development. WP9 – Prospective collection and WP10 – Dissemination and Exploitation. 

Visit Website

Follow Us

@projectetris

⏳ Calling all researchers in radiation oncology!
The deadline to submit your abstract for ESTRO 2027 is approaching!

An important opportunity to share your research, present scientific advances and connect with the international radiation oncology community.

📅 Abstract submission deadline: 11 November 2026
🔗 Submit your abstract: https://bit.ly/4zvNufW

#ESTRO2027 #TETRISproject #RadiationOncology #Radiotherapy #CancerResearch #ScientificResearch #HorizonEurope

1 0
Open post by projectetris with ID 17919822264448969
⏳ Calling all researchers in radiation oncology! The deadline to submit your abstract for ESTRO 2027 is approaching! An important opportunity to share your research, present scientific advances and connect with the international radiation oncology community. 📅 Abstract submission deadline: 11 November 2026 🔗 Submit your abstract: https://bit.ly/4zvNufW #ESTRO2027 #TETRISproject #RadiationOncology #Radiotherapy #CancerResearch #ScientificResearch #HorizonEurope

1 0

🇸🇪 The 3rd TETRIS General Assembly has successfully concluded in Stockholm!

On 8-9 October, the TETRIS consortium gathered at the Karolinska Comprehensive Cancer Centre, hosted by our partner Karolinska University Hospital, for two days of scientific exchange, collaboration and discussions on the project`s progress and next steps. Fondazione IRCCS Istituto Nazionale dei Tumori @istituto_tumori Vall d’Hebron Institute of Oncology - VHIO @vhiobarcelona @polimi @unisr @gmxenomica @AQUILAB by Coexya @Neolys Diagnostics

The meeting brought together consortium partners, Scientific Advisory Board members, Professor Alfons Hoekstra and Professor Carolyn Taylor, and patient representatives, Bröstcancerföreningen Amazona Stockholm and Associazione Cuore di Donna, providing an important opportunity to share results, exchange perspectives and strengthen collaboration across the different areas of research. @bcfamazona @brostcancerforeningen_amazona @associazione_cuoredidonna @Associazione Cuore di Donna

💡 Many key takeaways emerged from these two days, from making better use of existing clinical data to advance personalised risk prediction and exploring the potential of Digital Twins, to strengthening patient involvement and translating scientific advances into meaningful improvements in post-treatment care.

The General Assembly also featured educational sessions on AI in radiotherapy and Male breast cancer, broadcast from Stockholm and delivered by Maria Carmen De Santis from Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, as well as valuable contributions from our Scientific and Patient Advisory Boards.

👏 Our sincere thanks to Karolinska University Hospital for hosting the meeting, to our Scientific Advisors, Patient Representatives and all project partners for their active participation and contributions.

👉 Read the full news and discover the highlights and key outcomes of our 3rd General Assembly on the TETRIS website: urlr.me/nwQyNT.

#TETRISproject #TETRISGeneralAssembly #BreastCancer #Radiotherapy #DigitalTwins #PersonalisedMedicine #PatientCentredCare #CancerResearch #HorizonEurope

11 0
Open post by projectetris with ID 18113850323030370
🇸🇪 The 3rd TETRIS General Assembly has successfully concluded in Stockholm! On 8-9 October, the TETRIS consortium gathered at the Karolinska Comprehensive Cancer Centre, hosted by our partner Karolinska University Hospital, for two days of scientific exchange, collaboration and discussions on the project's progress and next steps. Fondazione IRCCS Istituto Nazionale dei Tumori @istituto_tumori Vall d’Hebron Institute of Oncology - VHIO @vhiobarcelona @polimi @unisr @gmxenomica @AQUILAB by Coexya @Neolys Diagnostics The meeting brought together consortium partners, Scientific Advisory Board members, Professor Alfons Hoekstra and Professor Carolyn Taylor, and patient representatives, Bröstcancerföreningen Amazona Stockholm and Associazione Cuore di Donna, providing an important opportunity to share results, exchange perspectives and strengthen collaboration across the different areas of research. @bcfamazona @brostcancerforeningen_amazona @associazione_cuoredidonna @Associazione Cuore di Donna 💡 Many key takeaways emerged from these two days, from making better use of existing clinical data to advance personalised risk prediction and exploring the potential of Digital Twins, to strengthening patient involvement and translating scientific advances into meaningful improvements in post-treatment care. The General Assembly also featured educational sessions on AI in radiotherapy and Male breast cancer, broadcast from Stockholm and delivered by Maria Carmen De Santis from Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, as well as valuable contributions from our Scientific and Patient Advisory Boards. 👏 Our sincere thanks to Karolinska University Hospital for hosting the meeting, to our Scientific Advisors, Patient Representatives and all project partners for their active participation and contributions. 👉 Read the full news and discover the highlights and key outcomes of our 3rd General Assembly on the TETRIS website: urlr.me/nwQyNT. #TETRISproject #TETRISGeneralAssembly #BreastCancer #Radiotherapy #DigitalTwins #PersonalisedMedicine #PatientCentredCare #CancerResearch #HorizonEurope

11 0